These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31638226

  • 1. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line.
    Han J, Tang Y, Zhong M, Wu W.
    Mol Med Rep; 2019 Dec; 20(6):5064-5074. PubMed ID: 31638226
    [Abstract] [Full Text] [Related]

  • 2. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ, Xia ZG, Wang AH, Wang WF, Liu ZY, Chen LY, Li JM.
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [Abstract] [Full Text] [Related]

  • 3. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY, Auerbach A, D'Costa AM, Rapoport AP, Burger AM, Sausville EA, Stass SA, Jiang F, Sands AM, Aguilera N, Zhao XF.
    Clin Cancer Res; 2009 Mar 01; 15(5):1708-20. PubMed ID: 19223503
    [Abstract] [Full Text] [Related]

  • 4. Effects of 1,25 and 24,25 Vitamin D on Corneal Epithelial Proliferation, Migration and Vitamin D Metabolizing and Catabolizing Enzymes.
    Lu X, Chen Z, Mylarapu N, Watsky MA.
    Sci Rep; 2017 Dec 05; 7(1):16951. PubMed ID: 29208972
    [Abstract] [Full Text] [Related]

  • 5. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ.
    Cancer Res; 2006 Jul 01; 66(13):6589-97. PubMed ID: 16818631
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK.
    Oncotarget; 2015 Jun 20; 6(17):15035-49. PubMed ID: 25909227
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma.
    Ezell SA, Wang S, Bihani T, Lai Z, Grosskurth SE, Tepsuporn S, Davies BR, Huszar D, Byth KF.
    Oncotarget; 2016 Feb 23; 7(8):9163-74. PubMed ID: 26824321
    [Abstract] [Full Text] [Related]

  • 8. CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)2D3 Through Downregulation of the WNT/β-Catenin Pathway and Methylation-Mediated Regulation of CYP24A1 in Colorectal Cancer Cells.
    Sun H, Jiang C, Cong L, Wu N, Wang X, Hao M, Liu T, Wang L, Liu Y, Cong X.
    DNA Cell Biol; 2018 Sep 23; 37(9):742-749. PubMed ID: 30052060
    [Abstract] [Full Text] [Related]

  • 9. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M, Lee SM, Pike JW, Jones G.
    Endocrinology; 2015 Dec 23; 156(12):4388-97. PubMed ID: 26441239
    [Abstract] [Full Text] [Related]

  • 10. Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma.
    Liu J, Chang YT, Kou YY, Zhang PP, Dong QL, Guo RY, Liu LY, Lin HW, Yang F.
    Med Oncol; 2024 Jul 29; 41(9):212. PubMed ID: 39073639
    [Abstract] [Full Text] [Related]

  • 11. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Jul 29; 9():1601-26. PubMed ID: 25834400
    [Abstract] [Full Text] [Related]

  • 12. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G.
    Endocrinology; 2005 Feb 29; 146(2):825-34. PubMed ID: 15498883
    [Abstract] [Full Text] [Related]

  • 13. 1α,25-Dihydroxyvitamin D3 enhances TRPV6 transcription through p38 MAPK activation and GADD45 expression.
    Ishizawa M, Akagi D, Yamamoto J, Makishima M.
    J Steroid Biochem Mol Biol; 2017 Sep 29; 172():55-61. PubMed ID: 28578001
    [Abstract] [Full Text] [Related]

  • 14. In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements.
    Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW.
    Endocrinology; 2024 Sep 26; 165(11):. PubMed ID: 39363152
    [Abstract] [Full Text] [Related]

  • 15. 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes.
    Salles J, Chanet A, Giraudet C, Patrac V, Pierre P, Jourdan M, Luiking YC, Verlaan S, Migné C, Boirie Y, Walrand S.
    Mol Nutr Food Res; 2013 Dec 26; 57(12):2137-46. PubMed ID: 23929734
    [Abstract] [Full Text] [Related]

  • 16. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.
    Wang H, Wang J, Qu H, Wei H, Ji B, Yang Z, Wu J, He Q, Luo Y, Liu D, Duan Y, Liu F, Deng H.
    Endocrine; 2016 Nov 01; 54(2):348-359. PubMed ID: 27395420
    [Abstract] [Full Text] [Related]

  • 18. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
    Zang C, Eucker J, Liu H, Müller A, Possinger K, Scholz CW.
    Cancer Lett; 2013 Oct 10; 339(2):288-97. PubMed ID: 23200668
    [Abstract] [Full Text] [Related]

  • 19. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH, He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, Yang T, Chen XW, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Oct 10; 9():1555-84. PubMed ID: 25792811
    [Abstract] [Full Text] [Related]

  • 20. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
    Wanner K, Hipp S, Oelsner M, Ringshausen I, Bogner C, Peschel C, Decker T.
    Br J Haematol; 2006 Sep 10; 134(5):475-84. PubMed ID: 16856892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.